The University of Arizona

Tracy A Brooks

Eugene W Gerner

Vijay Gokhale

Jenaro Garcia-Huidobro

Patricia Thompson

Venkateshwar R Chappeta

Cynthia Miranti

Elsa Reyes Reyes

Biswanath De

This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a quindoline (or similar) structure which function as stabilizers of G-quadruplex (G4) formation, and their use as therapeutics for the treatment of cancer (e.g., castration-resistant prostate cancer), and other conditions mediated by G4 stabilization.

Quindoline compounds and uses thereof

The present invention provides methods and kits a) for preventing and/or treating cancer (e.g., colorectal cancer, neuroblastoma) that is linked, in part, to high levels of ODC activity and increased cellular polyamine content, b) for predicting cancer patient survival, especially cancer patient's whose cancer is linked, in part, to high levels of ODC activity and increased cellular polyamine contents, and c) for selecting the corresponding treatment options for such patients based on the allelic nucleotide sequence or SNP at positions +263 and/or +316 of the ODC1 gene as well as cancer treatment methods, in each case, which include the determination of the ODC1 genotype at the +263 and/or +316 positions, as a means to guide treatment selection.

Carcinoma diagnosis and treatment based on ODC1 genotype

Growing community of inventors

Tucson, AZ, United States of America

Tracy A Brooks